Similar articles

• HIV vaccines. Viral envelope fails to deliver?

  Bolognesi DP, Matthews TJ. Bolognesi DP, et al. Nature. 1998 Feb 12;391(6668):638-9. doi: 10.1038/35504. Nature. 1998. PMID: 9490406 No abstract available.
• Vaccines for control of HIV infections.

  Sharma KB. Sharma KB. J Indian Med Assoc. 1994 Jan;92(1):27-8. J Indian Med Assoc. 1994. PMID: 8207277 No abstract available.
• Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines.

  Ferrantelli F, Cafaro A, Ensoli B. Ferrantelli F, et al. Curr Opin Biotechnol. 2004 Dec;15(6):543-56. doi: 10.1016/j.copbio.2004.10.008. Curr Opin Biotechnol. 2004. PMID: 15560981 Review.
• Update on HIV vaccines.

  Meldorf M, Corey L. Meldorf M, et al. STEP Perspect. 1997 Summer;9(2):5-6, 8-9. STEP Perspect. 1997. PMID: 11364929
• Novel adjuvants and delivery systems for HIV vaccines.

  O'Hagan DT, Lavelle E. O'Hagan DT, et al. AIDS. 2002;16 Suppl 4:S115-24. AIDS. 2002. PMID: 12699008 Review. No abstract available.